|4Aug 14, 4:47 PM ET

Almenoff June Sherie 4

4 · Avalo Therapeutics, Inc. · Filed Aug 14, 2024

Insider Transaction Report

Form 4
Period: 2024-08-13
Transactions
  • Award

    Restricted Stock Units

    2024-08-13+9,5009,500 total
    Common Stock (9,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-08-13+24,60024,600 total
    Exercise: $9.88Exp: 2034-08-13Common Stock (24,600 underlying)
Footnotes (3)
  • [F1]The stock option vests 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock upon the vesting date.
  • [F3]The RSUs vest 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT